Stalwart Tankers, which was recently formed to acquire and operate a fleet of mid-size chemical tankers, announced terms for its IPO on Wednesday. The Athens, Greece-based company plans to raise $150 million by offering 12.5 million shares at a price range of...read more
All four companies that were slated to go public this week successfully completed their deals, though three priced at the bottom of their proposed ranges and one was forced to cut its deal size by 18%. Two of the four IPOs, Baltic Trading Limited (BALT)...read more
Baltic Trading Limited, formed by Genco Shipping to acquire a spot market focused drybulk fleet, raised $228 million by offering 16.3 million shares at $14, at low end of the original range of $14-$16. Baltic Trading Limited will list on the NYSE under the...read more
The following IPOs are expected to price this week:
AVEO Pharmaceuticals, which is developing a renal cell carcinoma drug similar to blockbuster Avastin, plans to raise $98 million by offering 7 million shares at a price range of $13-$15. At the...read more
Chemical transportation company Stalwart Tankers sets terms for $150 million IPO
Stalwart Tankers, which was recently formed to acquire and operate a fleet of mid-size chemical tankers, announced terms for its IPO on Wednesday. The Athens, Greece-based company plans to raise $150 million by offering 12.5 million shares at a price range of...read more
Four IPOs test investor appetite, post mixed performances this week
All four companies that were slated to go public this week successfully completed their deals, though three priced at the bottom of their proposed ranges and one was forced to cut its deal size by 18%. Two of the four IPOs, Baltic Trading Limited (BALT)...read more
Baltic Trading prices IPO at $14, at low end of the range
Baltic Trading Limited, formed by Genco Shipping to acquire a spot market focused drybulk fleet, raised $228 million by offering 16.3 million shares at $14, at low end of the original range of $14-$16. Baltic Trading Limited will list on the NYSE under the...read more
4 IPOs planned for the week of Mar 8
The following IPOs are expected to price this week:
AVEO Pharmaceuticals, which is developing a renal cell carcinoma drug similar to blockbuster Avastin, plans to raise $98 million by offering 7 million shares at a price range of $13-$15. At the...read more